Loading clinical trials...
Loading clinical trials...
A Prospective Multi-center Study: Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy After Neoadjuvant Therapy in Breast Cancer
Conditions
Interventions
CEUS
blue dye
Locations
1
China
The first affiliated hospital of Sun Yat-Sen university
Guangzhou, Guangdong, China
Start Date
June 15, 2021
Primary Completion Date
July 15, 2023
Completion Date
August 15, 2023
Last Updated
June 21, 2021
NCT07191730
NCT06312176
NCT06797635
NCT07003841
NCT04511039
NCT07085442
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions